Tijl Vermassen

15PUBLICATIONS
27CO-AUTHORS
Regenerative medicine (incl. stem cells)Medical infection agents (incl. prions)Predictive and prognostic markersEvolutionary ecologySolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Dec 11, 2025
A Comprehensive Review of SSTR-Based Spect and Pet Imaging in Chronic Inflammatory and Immune-Mediated Diseases.

Shaobo Li, Alex Maes, Tijl Vermassen

|Jul 29, 2025
PET and SPECT Imaging of Macrophages in the Tumor Stroma: An Update.

Shaobo Li, Alex Maes, Tijl Vermassen

|Feb 25, 2025
Prognostication of Brain-Metastasized Patients Receiving Subsequent Systemic Therapy: A Single-Center Long-Term Follow-Up.

Tijl Vermassen, Charlotte Van Parijs, Stijn De Keukeleire

|May 25, 2024
The Association between Urine N-Glycome and Prognosis after Initial Therapy for Primary Prostate Cancer.

Tijl Vermassen, Nicolaas Lumen, Charles Van Praet

|Jan 30, 2024
Comparison of different estimated glomerular filtration rates for monitoring of kidney function in oncology patients.

Tijl Vermassen, Karen Geboes, Nicolaas Lumen

|Jan 16, 2024
Choice of surgery in intestinal-type adenocarcinoma of the sinonasal tract: a long-term comparative study.

Tijl Vermassen, Stijn De Keukeleire, Michael Saerens

Pageof 3